Home › Funds › CVS HEALTH Corp › XLV
CVS HEALTH Corp position in XLV
SELECT SECTOR SPDR TR
CVS HEALTH Corp reported holding 50,000 shares of XLV (SELECT SECTOR SPDR TR) in its Q3 2026 13F filing — a position valued at US$8.4M, representing 1.96% of its reported portfolio and ranking #14 among its reported holdings. CVS HEALTH Corp has disclosed XLV holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How CVS HEALTH Corp's XLV position evolved
CVS HEALTH Corp first disclosed a stake in XLV in Q1 2026 at 12,000 shares (US$1.8M). The position peaked in Q3 2026 at 50,000 shares, worth US$8.4M. Across 2 filings, CVS HEALTH Corp held the position steady without any share-count change. The most recent filing (Q3 2026) shows 50,000 shares valued at US$8.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 12.00K | $1.76M | New |
| Q3 2026 | 50.00K | $8.42M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XLV and 13F data
XLV (SELECT SECTOR SPDR TR) is a company whose sector is not yet classified in our data. 28 other funds we track also report a position in XLV — the largest reported positions include RAYMOND JAMES FINANCIAL INC (US$820.3M), Harel Insurance Investments & Financial Services Ltd. (US$574.7M), JANE STREET GROUP, LLC (US$556.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XLV
- RAYMOND JAMES FINANCIAL INC 4.87M sh · $820.33M · Q3 2026
- Harel Insurance Investments & Financial Services Ltd. 3.41M sh · $574.69M · Q3 2026
- JANE STREET GROUP, LLC 3.30M sh · $555.95M · Q3 2026
- Focus Partners Wealth 2.70M sh · $455.45M · Q3 2026
- TRUIST FINANCIAL CORP 2.25M sh · $378.51M · Q3 2026
- Janney Montgomery Scott LLC 2.16M sh · $363.88M · Q3 2026
- WestEnd Advisors, LLC 1.75M sh · $294.56M · Q3 2026
- CDPQ (Caisse de Depot) 1.69M sh · $268.65M · Q2 2026
- CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 1.69M sh · $268.65M · Q2 2026
- MENORA MIVTACHIM HOLDINGS LTD. 1.67M sh · $264.90M · Q2 2026
- OSAIC HOLDINGS, INC. 1.52M sh · $255.86M · Q3 2026
- Jordan Park Group LLC 1.39M sh · $234.55M · Q3 2026
More on CVS HEALTH Corp
FAQ
How long has CVS HEALTH Corp held XLV?
CVS HEALTH Corp has disclosed XLV holdings in 2 of the last 3 reported quarters, going back to Q1 2026.
What is CVS HEALTH Corp's current position in XLV?
As of Q3 2026, CVS HEALTH Corp holds 50.00K shares of XLV (SELECT SECTOR SPDR TR), valued at $8.42M, representing 1.96% of its reported portfolio and ranking #14.
Has CVS HEALTH Corp been buying or selling XLV?
In the latest 13F filing (Q3 2026), CVS HEALTH Corp newly opened its position in XLV. The position peaked in Q3 2026 at 50.00K shares.
Which other funds hold XLV?
Other major institutional holders of XLV include RAYMOND JAMES FINANCIAL INC, Harel Insurance Investments & Financial Services Ltd., JANE STREET GROUP, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.